Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12264669 | PMC |
| http://dx.doi.org/10.9758/cpn.24.1232.corr | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human Papillomavirus Type and Viral Load in Relation to Circulating Cell-Free Tumour HPV DNA Level and Survival in Cervical Cancer.
Mol Diagn Ther
August 2025
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Background And Objective: Human papillomavirus (HPV) is the cause of most cervical cancers and is released as circulating cell-free tumour HPV DNA (ctHPV DNA) into circulation. Earlier studies have indicated that ctHPV DNA is a promising biomarker for analysing treatment response and for recurrence surveillance. However, factors influencing the release of ctHPV DNA, including HPV type and HPV viral load, have not been extensively studied and additional biomarkers for prognosis are needed.
View Article and Find Full Text PDFicuRESOLVE-D (Intensive Care Unit REcovery Solutions cO-Led through surVivor Engagement-Digital): Protocol for a multicentre randomised controlled trial of digital peer support for adult survivors of critical illness.
Aust Crit Care
August 2025
Department of Critical Care, Melbourne Medical School, The University of Melbourne, Australia; Department of Intensive Care, Melbourne Health, Melbourne, Australia.
Background: Peer support is a candidate intervention to improve health-related quality of life in survivors of critical illness. This trial will evaluate the effect of a codesigned digital peer support intervention (expert-facilitated, web-based peer support) compared to usual care.
Design: This study is planned as a randomised, multicentre, two-arm, parallel-group (1:1) hybrid effectiveness implementation trial of a digital peer support model versus usual care.
Addendum: Factors Affecting Continuation of Aripiprazole Long-acting Injection in the Real World.
Clin Psychopharmacol Neurosci
August 2025
Department of Psychiatry, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
An international multi-cohort investigation of self-reported sleep and future depressive symptoms in older adults.
Sci Rep
July 2025
Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Poor subjective sleep is associated with future depression in older adults, but there is limited consensus on which sleep features have the strongest associations. Moreover, composite scores incorporating multiple features may better represent sleep burden than individual sleep items. We analyzed older adults (age ≥ 60) without clinically relevant depressive symptoms from a multi-cohort United States sample (US; N = 4826) and the Netherlands' Rotterdam Study (RS; N = 3663), with the goal of identifying individual and composite sleep features that are associated with future clinically relevant depressive symptoms 3-6 years later.
View Article and Find Full Text PDF30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum Study.
JACC Cardiovasc Interv
August 2025
OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.
Background: Primary results from the Optimize PRO study demonstrated that transcatheter aortic valve replacement (TAVR) with the cusp overlap technique (COT) resulted in low 30-day permanent pacemaker implantation (PPI) rates and no moderate or greater aortic regurgitation (AR).
Objectives: The aim of this study was to evaluate outcomes after Evolut FX implantation using the COT and postprocedural computed tomography (CT).
Methods: The Optimize PRO FX Addendum study is a postmarket, prospective, multicenter, nonrandomized study.